Tags: gene therapy

1/8/2018

CNN wisely challenges $425,000 price for gene therapy, but what about the claims of effectiveness?

12/12/2017

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

10/10/2017

New York Times is upfront about risk of ‘absolutely crazy’ prices for gene therapy treatment

10/10/2017

AP makes it clear that gene therapy has uncertain future for treating ALD

7/18/2017

Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000

3/6/2017

AP doesn’t sugar coat harms of CAR-T therapy for lymphoma

10/26/2016

CBS’s look at a preliminary trial using gene therapy needed more on downsides and unknowns

5/3/2016

With no discussion on limits of animal research, Newsweek story adds to hype on gene therapy

8/10/2011

Gene Therapy Cures Adult Leukemia

8/10/2011

Gene therapy shown to destroy leukemia tumors

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Elizabeth Kay Mendes @LizKayMendes·

“to project certainty where it simply does not exist is communication malpractice at a time like this and with a public health issue like this.” ⁦@garyschwitzer⁩ on ⁦@ContentScience⁩ https://review.content-science.com/covering-covid-19-vaccine-news-part-two-from-the-publisher-of-health-news-review/

Reply on Twitter 1291075113526464512 Retweet on Twitter 12910751135264645123 Like on Twitter 12910751135264645122 Twitter 1291075113526464512

Retweet on Twitter HealthNewsReview.org Retweeted

Elaine Schattner MD, MA @ESchattner·

In case you weren't aware: Prestigious journalism organizations and outlets take money from pharma, @garyschwitzer https://www.healthnewsreview.org/2020/08/drug-company-influence-on-journalism/#.XyrYGZeNvXA.twitter @HealthNewsRevu

Reply on Twitter 1291042197752745985 Retweet on Twitter 12910421977527459851 Like on Twitter 12910421977527459851 Twitter 1291042197752745985

Retweet on Twitter HealthNewsReview.org Retweeted

Kim Walsh-Childers @WalshChilders·

Addressing conflicts of interest ought to be a standard part of EVERY drug story. Journalism professors ought to be teaching students this, just as they teach them to include name, age and other standard story information. https://twitter.com/garyschwitzer/status/1290973141758611459

Reply on Twitter 1291042173929107464 Retweet on Twitter 12910421739291074641 Like on Twitter 12910421739291074644 Twitter 1291042173929107464

Tags: gene therapy

CNN wisely challenges $425,000 price for gene therapy, but what about the claims of effectiveness?

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

New York Times is upfront about risk of ‘absolutely crazy’ prices for gene therapy treatment

AP makes it clear that gene therapy has uncertain future for treating ALD

Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000

AP doesn’t sugar coat harms of CAR-T therapy for lymphoma

CBS’s look at a preliminary trial using gene therapy needed more on downsides and unknowns

With no discussion on limits of animal research, Newsweek story adds to hype on gene therapy

Gene Therapy Cures Adult Leukemia

Gene therapy shown to destroy leukemia tumors

Story Reviews

@HealthNewsRevu

Categories

Tags